sirolimus and Skin-Diseases--Viral

sirolimus has been researched along with Skin-Diseases--Viral* in 2 studies

Other Studies

2 other study(ies) available for sirolimus and Skin-Diseases--Viral

Article	Year
Disseminated herpes simplex virus type-1 infection in long-term usage of everolimus. The Journal of dermatology, 2013, Volume: 40, Issue:1 Topics: Carcinoma, Renal Cell; Drug Therapy, Combination; Everolimus; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Prednisolone; Sirolimus; Skin Diseases, Viral; Time Factors; Virus Activation	2013
Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:12 Dermatological complications following transplantation are very common and the majority of immunosuppressed transplant recipients develop some to many warts due to human papillomavirus (HPV) infection. In the setting of immunosuppression, therapeutic management may be disappointing because of the extent of the lesions in patients unable to develop a sufficient immune response directed against HPV. We report here a case of a young liver transplant recipient who developed diffuse recalcitrant HPV-induced warts leading to an impairment of her quality of life. Taking into account the antiproliferative and cytostatic properties of the target-of-rapamycin (TOR) inhibitors, a new class of immunosuppressive drug, we significantly modified the immunosuppressive regimen. Conversion to sirolimus was followed by a rapid improvement of cutaneous state suggesting that this strategy may be useful for recalcitrant cutaneous viral warts in transplant recipient. Topics: Adolescent; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Papillomavirus Infections; Sirolimus; Skin Diseases, Viral; Warts	2006

Article

Year

Disseminated herpes simplex virus type-1 infection in long-term usage of everolimus.

The Journal of dermatology, 2013, Volume: 40, Issue:1

Topics: Carcinoma, Renal Cell; Drug Therapy, Combination; Everolimus; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Prednisolone; Sirolimus; Skin Diseases, Viral; Time Factors; Virus Activation

2013

Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006, Volume: 12, Issue:12

Dermatological complications following transplantation are very common and the majority of immunosuppressed transplant recipients develop some to many warts due to human papillomavirus (HPV) infection. In the setting of immunosuppression, therapeutic management may be disappointing because of the extent of the lesions in patients unable to develop a sufficient immune response directed against HPV. We report here a case of a young liver transplant recipient who developed diffuse recalcitrant HPV-induced warts leading to an impairment of her quality of life. Taking into account the antiproliferative and cytostatic properties of the target-of-rapamycin (TOR) inhibitors, a new class of immunosuppressive drug, we significantly modified the immunosuppressive regimen. Conversion to sirolimus was followed by a rapid improvement of cutaneous state suggesting that this strategy may be useful for recalcitrant cutaneous viral warts in transplant recipient.

Topics: Adolescent; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Papillomavirus Infections; Sirolimus; Skin Diseases, Viral; Warts

2006